| General Information of Drug Metabolite (DM) (ID: DM006386) |
| DM Name |
Empagliflozin-2-glucuronide
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 1A3 (UGT1A3)
|
DME0041
|
| Conjugation - O-glucuronidation |
Empagliflozin
|
[1] |
|
UDP-glucuronosyltransferase 1A8 (UGT1A8)
|
DME0064
|
| Conjugation - O-glucuronidation |
Empagliflozin
|
[1] |
|
UDP-glucuronosyltransferase 1A9 (UGT1A9)
|
DME0042
|
| Conjugation - O-glucuronidation |
Empagliflozin
|
[1] |
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME0040
|
| Conjugation - O-glucuronidation |
Empagliflozin
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Empagliflozin |
DR1755
|
Approved |
Diabetes mellitus |
|
|
| References |
| 1 |
Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
